#734 — The Industry Wire

August 27, 2025 Brian Casey 0 min read
  1. CDC director ousted after just a few weeks on the job.
  2. Why a ‘two-tier Medicare system’ may be on the horizon.
  3. OpenAI expands healthcare team.
  4. Blue Shield of California names new President and CEO.
  5. Nonprofit hospital CEO, employee compensation gap widens.
  6. California hospital to close after CMS revokes critical access status.
  7. Pharma costs squeeze hospital margins.
  8. CDC attacker attempted to enter campus days before shooting.
  9. Adventist Health restructuring to affect 300 corporate roles.
  10. ‘Fear Pandemic’: Immigration raids push patients into telehealth.
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Radiology Education February 5, 2026

Residency Push Skips Radiology February 5, 2026

A federal push to alleviate the U.S. physician shortage by adding more resident training slots appears to have skipped radiology. Of the more than 400 residency programs awarded funding so far, only two diagnostic radiology programs got funds.  The ongoing doctor shortage has become a major issue in U.S. healthcare, as physicians face rising patient […]

Mammogram image

Artificial Intelligence February 2, 2026

More Positive News on Mammo AI from MASAI February 2, 2026

The latest results from the landmark MASAI study of AI for mammography screening show a favorable trend toward reducing the rate of interval cancers, or breast cancers that appear between screening rounds. The new findings – published Friday in The Lancet – also confirm mammography AI’s sharp workload reduction and trend toward higher sensitivity.  MASAI […]

Lung Cancer Screening January 29, 2026

Lung Cancer in Non-Smokers Creates Questions January 29, 2026

Behind the growing enthusiasm for CT lung cancer screening is a nagging question – should we be screening people who have never smoked too? It’s a dilemma that’s addressed in a new paper in Radiology that offers some insight. CT lung screening is the only major cancer screening test that’s exclusively targeted at high-risk individuals, […]